TGM2 and renal cell carcinoma: However, the anti-cancer effects of streptonigrin are based on inhibition of TGase 2 rather than on inhibition of PAD because the PAD inhibitor Cl-amidine does not have anti-cancer effects on RCC cell lines, see Figure S5.